Vyome Holdings, Inc. is building a healthcare platform spanning the US-India innovation corridor.

Vyome’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory and rare disease conditions. By applying groundbreaking science and taking the advantage of the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a very cost-efficient manner while upholding global standards of quality and safety.